| Symbol | RVTY |
|---|---|
| Name | REVVITY, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | 940 WINTER STREET, WALTHAM, Massachusetts, 02451, United States |
| Telephone | +1 781 663-6900 |
| Fax | — |
| — | |
| Website | https://www.revvity.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000031791 |
| Description | Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics. Additional info from NASDAQ: |
Revvity - Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration
Read moreRevvity Expands Signals AI Ecosystem Through Anthropic Claude Integration
Read moreNew Form 11-K - REVVITY, INC. <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 0001193125-26-279766 <b>Size:</b> 2 MB
Read moreRevvity - Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D
Read moreRevvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&D
Read moreNew Form SD - REVVITY, INC. <b>Filed:</b> 2026-06-01 <b>AccNo:</b> 0001193125-26-249770 <b>Size:</b> 38 KB
Read moreMICHAS ALEXIS P 🟢 acquired 2.7K shares of REVVITY, INC. (RVTY) Transaction Date: May 07, 2026 | Filing ID: 216736
Read moreVandebroek Sophie V. 🟢 acquired 2.3K shares of REVVITY, INC. (RVTY) Transaction Date: May 07, 2026 | Filing ID: 216734
Read moreKlobuchar Michael A 🟢 acquired 2.3K shares of REVVITY, INC. (RVTY) Transaction Date: May 07, 2026 | Filing ID: 216733
Read more